SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lorus Therapeutics LORFF LOR -- Ignore unavailable to you. Want to Upgrade?

To: Frank Moss who wrote (18)1/5/2000 1:27:00 PM
From: Gabe Heti  Respond to of 101
 
Canaccord actively buying this afternoon. Good sign.



To: Frank Moss who wrote (18)1/5/2000 4:05:00 PM
From: Gabe Heti  Respond to of 101
 
What a fun ride! Where is this thing heading?



To: Frank Moss who wrote (18)1/30/2000 5:24:00 AM
From: Nikki  Read Replies (1) | Respond to of 101
 
This is from April - not sure what year. I see that Lorus was Imutec in 1995 and working on Virizulin then, too. Still looks like it holds promise.

msnbc.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News